Company Unveils New Eco-Responsible Consumer Packaging and Enters eRetail Market
MONTREAL, Dec. 19, 2019 /CNW/ - Mondias Natural Products Inc. (TSXV: NHP) (the "Company" or "Mondias"), which specializes in evidence-based botanical products for the healthcare and bio-agriculture markets, today announced that it has launched its BazzzicsTM Sleep Aid product line. BazzzicsTM is a natural health product line with ingredients that have demonstrated efficacy for sleep and anxiety disorders. Each of the new products addresses a key element of sleep hygiene, namely, sleep anxiety, sleep onset or sleep maintenance. The products are made with a proprietary mix of plant-based extracts, including patented active ingredient CALPXT96.
Along with this new product line, the Company also wishes to announce that, as part of its commitment to improving its manufacturing and packaging practices, it will market BazzzicsTM products in an eco-responsible glass container with a natural bamboo lid. Purchases and product refills will be available to customers via the Company's online supply channel and packed in 100% recyclable and plastic-free kraft paper stand-up pouches that ensure product stability and efficacy.
"The entire Mondias team has worked diligently to create our new lineup of sleep aids. Working with our marketing partners, we've entered the digital retail space to accelerate product sales. The ability to move from concept, to manufacturing, to product launch; demonstrates our commitment to expanding our natural products portfolio. The Company is committed to exceptional growth while ensuring safe, effective and environmentally conscious products are available for our customers," says Dr. Patrick Frankham, CEO of Mondias.
According to industry reports, the global sleep aids market was valued at $49.5 billion in 2016 and is estimated to reach $79.9 billion by 2022, with a CAGR of 7.0% from 2017 to 2023. Sleep aids are drugs and devices that are used to diagnose and treat sleep disorders, such as sleep apnea and insomnia. Sleep disorders stem from substance misuse, a stressful work environment or an inconsistent sleep pattern. Sleep aids help improve sleep quality by reducing the time required to fall asleep and increasing the duration of quality sleep.
About BazzzicsTM Natural Sleep Aids BazzzicsTM sleep aids are all-natural sleep aid solutions with proven efficacy for sleep and anxiety disorders. BazzzicsTM features three innovative products (sold separately) that each address a unique sleep-related problem. BazzzicsTM ANXIETY helps relieve stress, worry, unease or nervousness, BazzzicsTM SLEEP ONSET helps initiate the sleeping process and BazzzicsTM SLEEP MAINTENANCE helps patients stay asleep. The three products are generally safe and unlike with many sleep medications, users are unlikely to become dependent, have diminished response after repeated use (habituation) or experience a hangover effect. The products feature at least two of the following four natural herbal extracts in various concentrations: California poppy, lemon balm, passionflower and skullcap. These ingredients are well known and traditionally used in herbal medicine as sleep aids and calmatives to help relieve restlessness or nervousness when under stress. Strong synergies and higher efficacy are expected when BazzzicsTM products are used in combination.
About Mondias Natural Products Inc. Mondias specializes in the commercialization and development of evidence-based botanical products for the healthcare, bio-agriculture and organic markets. The company sells both oral and topical botanical agents to help manage unmet medical needs through its Holizen Laboratories division. Mondias is also developing botanical-based specialty fertilizers for use on household plants, lawns and golf courses and in urban gardens, nurseries and greenhouses, in collaboration with McGill's Faculty of Agricultural and Environmental Sciences.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements Some statements in this release may contain forward-looking information. All statements, other than statements of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by the use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include the Company's inability to obtain sufficient financing to execute its business plan; competition; regulation; anticipated and unanticipated costs and delays; the success of the Company's research and development strategies; the ability to obtain orphan drug status; the applicability of the discoveries made; the successful and timely completion and uncertainties related to the regulatory approval process; the timing of clinical trials; the timing and outcomes of regulatory or intellectual property decisions; and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this news release, and the Company does not undertake any obligation to publicly update them to reflect new information or subsequent events or otherwise except as required by applicable securities legislation.
SOURCE Mondias Natural Products Inc.
For further information: Mondias Natural Products Inc., Patrick Frankham, PhD, MBA, Chief Executive Officer, 514-943-1899, [email protected]; Relations Publiques Paradox Inc., 514-341-0408